We encourage authors to provide detailed information within their submission to facilitate the interpretation and replication of experiments. Authors can upload supporting documentation to indicate the use of appropriate reporting guidelines for health-related
Sample-size estimation
 You should state whether an appropriate sample size was computed when the study was being designed  You should state the statistical method of sample size computation and any required assumptions  If no explicit power analysis was used, you should describe how you decided what sample (replicate) size (number) to use
Please outline where this information can be found within the submission (e.g., sections or figure legends), or explain why this information doesn't apply to your submission:
Replicates  You should report how often each experiment was performed  You should include a definition of biological versus technical replication  The data obtained should be provided and sufficient information should be provided to indicate the number of independent biological and/or technical replicates  If you encountered any outliers, you should describe how these were handled  Criteria for exclusion/inclusion of data should be clearly stated  High-throughput sequence data should be uploaded before submission, with a private link for reviewers provided (these are available from both GEO and ArrayExpress)
No explicit power analysis was used to predetermine sample size. The number of embryos and cell culture replicates were based on experimental considerations. This is detailed in the corresponding figure legend for each experiment.
eLife Sciences Publications, Ltd is a limited liability non-profit non-stock corporation incorporated in Please outline where this information can be found within the submission (e.g., sections or figure legends), or explain why this information doesn't apply to your submission:
(For large datasets, or papers with a very large number of statistical tests, you may upload a single table file with tests, Ns, etc., with reference to sections in the manuscript.)
Group allocation  Indicate how samples were allocated into experimental groups (in the case of clinical studies, please specify allocation to treatment method); if randomization was used, please also state if restricted randomization was applied  Indicate if masking was used during group allocation, data collection and/or data analysis Please outline where this information can be found within the submission (e.g., sections or figure legends), or explain why this information doesn't apply to your submission:
The number of mutant embryos, pools of embryos, and cell culture replicates are indicated in the corresponding figure legend. For mutant embryos, at least 3 independent embryos were analysed (between 3 and 11). Analysis of single blastomeres were always related to more than one embryo (from 75 to 428 blastomeres, between 2 and 6 blastocysts, and 28 morulae). Transient transgenic assays were performed, at least, in 75 embryos. Between 4 and 13 pools of embryos were used for RT-qPCR analysis. Cell culture assays were performed, at least, in 6 replicates. Sequencing data has been uploaded to GEO database with the following accession number GSE121979. 3 Additional data files ("source data")  We encourage you to upload relevant additional data files, such as numerical data that are represented as a graph in a figure, or as a summary table  Where provided, these should be in the most useful format, and they can be uploaded as "Source data" files linked to a main figure or table  Include model definition files including the full list of parameters used  Include code used for data analysis (e.g., R, MatLab)  Avoid stating that data files are "available upon request" Please indicate the figures or tables for which source data files have been provided: 2 different source data have been associated to Figure 5 ( Figure 5 -source data 1 and Figure 5 -source data 2). These correspond to bioinformatics analysis performed in the RNAseq experiment.
